T1	Participants 151 171	type III prostatitis
T2	Participants 192 260	242 patients with type III prostatitis diagnosed by the NIH criteria
T3	Participants 352 510	treated with Compound Xuanju Capsule + Tamsulosin Hydrochloride, and the latter with Quinolinone antibiotics + Tamsulosin and Hydrochloride, both for 6 months
T4	Participants 649 693	All the 242 patients completed the treatment
T5	Participants 843 924	47.10% (57/121) in the control group, 31.78% (34/107) in those with complications
